Ratings Aviva plc Deutsche Boerse AG

Equities

GU80

US05382A3023

Delayed Deutsche Boerse AG Other stock markets 02:31:29 2024-07-17 EDT			5-day change	1st Jan Change
11.3 ^EUR	+1.80%		+4.63%	+20.21%

07-15	FTSE 100 ends lower on Burberry profit warning, US political worries	RE
07-12	Major investors pile in to UK rental homes despite regulatory fears	RE

Summary

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

The company's attractive earnings multiples are brought to light by a P/E ratio at 11.24 for the current year.
Given the positive cash flows generated by its business, the company's valuation level is an asset.
The company is one of the best yield companies with high dividend expectations.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The company sustains low margins.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.

Ratings chart - Surperformance

Sector: Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
AVIVA PLC	+20.21%	16.65B	-
AXA	+8.58%	76.65B	B-
METLIFE, INC.	+15.97%	53.8B	B+
AFLAC INCORPORATED	+14.55%	53.16B	B
MANULIFE FINANCIAL CORPORATION	+23.70%	47.66B	B+
PRUDENTIAL FINANCIAL, INC.	+23.36%	45.43B	B+
GENERALI	+22.48%	39.28B	B
CHINA PACIFIC INSURANCE (GROUP) CO., LTD.	+23.30%	33.57B	B
CATHAY FINANCIAL HOLDING CO., LTD.	+42.73%	29.38B	A
SUN LIFE FINANCIAL INC.	+1.06%	29.33B	B

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes